MAGI2 and nasopharyngeal carcinoma: This study not only found that MAGI2-AS3 was elevated in NPC cell lines (especially CNE1 and SUNE1), but also determined that it promoted cell proliferation, migration and EMT processing, and even contributed to the cisplatin resistance of NPC cells, thus clearly indicating its oncogenic functions [51].